![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Illuminare-1 is a single dose injectable myelin binding fluorescent agent currently in development to provide real time visualization and delineation of nerves potentially as small as ~60 micron during both open and minimally invasive surgery under blue light illumination.
Lead Product(s): Illuminare-1
Therapeutic Area: Oncology Product Name: Illuminare-1
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 23, 2023